No Data
No Data
No Data
No Data
No Data
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the consensus estimate loss of $(3.55).The company reported sales of $167
BenzingaMay 2 13:12 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out
BenzingaMay 2 12:31 ET
Express News | Metagenomi Shares Are Trading Lower After Moderna and the Company Mutually Agreed to Terminate Their Collaboration on Primary Hyperoxaluria Type 1 and Rights to Develop the PH1 Program. Also, JP Morgan Downgraded the Stock From Overweight to Neutral and L
BenzingaMay 2 11:58 ET
Metagenomi Cut to Neutral From Overweight by JP Morgan
Metagenomi Cut to Neutral From Overweight by JP Morgan
Dow JonesMay 2 08:42 ET
Express News | JP Morgan Downgrades Metagenomi to Neutral, Lowers Price Target to $6
BenzingaMay 2 08:32 ET
Express News | Metagenomi Inc : Chardan Capital Markets Cuts Target Price to $17 From $21
ReutersMay 2 07:51 ET
No Data
No Data